Netherlands· NL-107ae9dd620c
Glentek 50 mg filmomhulde tabletten
A riluzole product containing riluzol, registered in Netherlands by Glenmark Arzneimittel GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Riluzole is registered in 17 of 19 countries.
Countries holding a registration under ATC N07XX02 (riluzole), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Riluzole · ATC N07XX02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of riluzole costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $5.62 in France to $9.14 in Italy — a ×1.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Riluzole · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- IT Italy$9.14
- CH Switzerland$8.63
- FR France$5.62
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RILUZOL
- Manufacturer
- Glenmark Arzneimittel GmbH
- Country
- Netherlands (NL)
- ATC code
- N07XX02
- ATC class
- Riluzole
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id109825
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
46 interactions on record for riluzole.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Riluzole · interactions on record
46 records
- 4 severe
- 28 moderate
- 5 minor
- 9 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Riluzole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRILUTEKSanofi Winthrop Industrie, Gentilly
- FranceRILUTEK 50 mg, comprimé pelliculéSANOFI WINTHROP INDUSTRIE
- SwedenGlentek 50 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
- FinlandRilutekParanova Oy
- BelgiumRiluzol AB 50 mgAurobindo
- SpainRILUTEK 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULASanofi Winthrop Industrie
- ItalyRILUTEKSANOFI WINTHROP INDUSTRIE
- PolandRilutekSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emylif, Riluzol Aristo
- Belgium · Emylif, Riluzol Ab
- Cyprus · Teglutik
- Czechia · Riluzol Pmcs
- Germany · Emylif, Glentek
- Denmark · Emylif, Glentek
- Estonia · Lizolorol, Rilustad
- Spain · Emylif, Riluzol Aurovitas
- Finland · Teglutik
- France · Emylif, Riluzole Arrow
- United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
- Greece · Teglutik
- Croatia · Alsemol
- Hungary · Sclefic
- Iceland · Emylif, Rilutek
- Italy · Emylif, Riluzolo Aurobindo
- Liechtenstein · Rilutek, Riluzole Zentiva
- Luxembourg · Emylif, Teglutik
- Norway · Emylif, Rilutek
- Poland · Riluzol Pmcs, Riluzole Sun
- Portugal · Emylif, Riluzol Aurovitas
- Romania · Riluzol Pmcs
- Sweden · Emylif, Glentek
- Slovenia · Sclefic
- Slovakia · Riluzol Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/434fb377-3a15-441f-90be-6ffd1050781a GET /v1/drugs/434fb377-3a15-441f-90be-6ffd1050781a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h109825_smpc.pdf",
"strength": null,
"atc_label": "Riluzole",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg109825",
"excipients": [
"CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"HYPROMELLOSE (E 464)",
"MACROGOL 400",
"MAGNESIUMSTEARAAT (E 470b)",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"RILUZOL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h109825.pdf",
"authorised_at": "2012/07/20",
"procedure_number": "NL/H/4645/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "109825",
"additional_monitoring": "N"
}See everything about riluzole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.